Serum microRNA signature for the diagnosis of clinically significant prostate cancer

被引:0
|
作者
Alhasan, Ali [1 ]
机构
[1] KACST, Life Sci & Environm Res Inst, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
326
引用
收藏
页数:1
相关论文
共 50 条
  • [1] PSA VARIABILITY AND THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER
    Vilson, Fernandino
    Zhang, Boya
    Brooks, James
    Osborne, Thomas
    Ray, Priyadip
    Leppert, John
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E501 - E501
  • [2] Improving the evaluation and diagnosis of clinically significant prostate cancer
    Kryvenko, Oleksandr N.
    Epstein, Jonathan I.
    [J]. CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 191 - 197
  • [3] A microRNA signature in urinary exosomes for diagnosis of prostate cancer
    Blonde, Thorarinn
    Rasmussen, Anne I.
    Thomsen, Anni R.
    Borre, Michael
    Fredsoe, Jacob
    Andreasen, Ditte
    Orntoft, Torben Falck
    Sorensen, Karina D.
    Mouritzen, Peter
    [J]. CANCER RESEARCH, 2016, 76
  • [4] A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
    Drago, Denise
    Andolfo, Annapaola
    Mosca, Ettore
    Orro, Alessandro
    Nocera, Luigi
    Cucchiara, Vito
    Bellone, Matteo
    Montorsi, Francesco
    Briganti, Alberto
    [J]. CANCER BIOLOGY & MEDICINE, 2021, 18 (02) : 604 - +
  • [5] DEVELOPMENT AND VALIDATION OF A NOVEL EPS-METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER.
    Andolfo, Annapaola
    Drago, Denise
    Cucchiara, Vito
    Nocera, Luigi
    Mosca, Ettore
    Orro, Alessandro
    Bellone, Matteo
    Montorsi, Francesco
    Briganti, Alberto
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E220 - E220
  • [6] A novel expressed prostatic secretion(EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
    Denise Drago
    Annapaola Andolfo
    Ettore Mosca
    Alessandro Orro
    Luigi Nocera
    Vito Cucchiara
    Matteo Bellone
    Francesco Montorsi
    Alberto Briganti
    [J]. Cancer Biology & Medicine, 2021, 18 (02) : 604 - 615
  • [7] A panel of microRNA signature in serum for colorectal cancer diagnosis
    Zhu, Mingxia
    Huang, Zebo
    Zhu, Danxia
    Zhou, Xin
    Shan, Xia
    Qi, Lian-Wen
    Wu, Lirong
    Cheng, Wenfang
    Zhu, Jun
    Zhang, Lan
    Zhang, Huo
    Chen, Yan
    Zhu, Wei
    Wang, Tongshan
    Liu, Ping
    [J]. ONCOTARGET, 2017, 8 (10) : 17081 - 17091
  • [8] Serum and urine biomarkers for detecting clinically significant prostate cancer
    Becerra, Maria F.
    Atluri, Venkatasai S.
    Bhattu, Amit S.
    Punnen, Sanoj
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 686 - 690
  • [9] Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017
    Carlsson, Sigrid V.
    Roobol, Monique J.
    [J]. CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 198 - 204
  • [10] The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
    Park, Jee Soo
    Koo, Kyo Chul
    Chun, Byung Ha
    Lee, Kwang Suk
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2019, 60 (06) : 442 - 446